Quarterly report pursuant to Section 13 or 15(d)

Notes Payable (Details Narrative)

v3.3.1.900
Notes Payable (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
May. 01, 2015
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Feb. 20, 2015
Debt Instrument [Line Items]            
Number of common stock purchased by issuance of warrants       150,000    
Common stock exercise price   $ 1.00   $ 1.00    
Relative fair value of warrant   $ (290,898) $ (1,219,889) $ (888,907) $ (1,504,254)  
Incremental compensation cost       192,147    
Amortization of debt discount   41,998  
Interest expense, net   $ 11,960 $ 11,537 21,019 $ 45,868  
October 2015 [Member]            
Debt Instrument [Line Items]            
Incremental compensation cost       $ 12,954    
Convertible Notes Payable [Member]            
Debt Instrument [Line Items]            
Convertible note principal amount           $ 200,000
Warrants term       5 years    
Number of common stock purchased by issuance of warrants 50,000     400,000    
Common stock exercise price $ 1.00 $ 1.00   $ 1.00    
Relative fair value of warrant $ 13,516     $ 23,641    
Accrued Interest at the Rate 2.00%          
Debt instrument maturity date Jun. 01, 2015          
Repayment to convertible note payable       100,000    
Converitable Notes Payable One [Member]            
Debt Instrument [Line Items]            
Repayment to convertible note payable       $ 71,585